Background/Objectives: Vitamin D deficiency is associated with cardiovascular disease, osteoporosis, poor muscle strength, falls, fractures and mortality. Although older adults are at a higher risk of vitamin D deficiency, the relationship of serum 25-hydroxyvitamin D (25(OH)D) with all-cause and cardiovascular disease mortality has not been well characterized in the elderly. We hypothesized that low serum 25(OH)D levels predicted mortality in older adults. Subjects/Methods: Serum 25(OH)D as well as all-cause and cardiovascular disease mortality were examined in 1006 adults, aged X65 years, who participated in the InCHIANTI (Invecchiare in Chianti, Aging in the Chianti Area) study, a population-based, prospective cohort study of aging in Tuscany, Italy. Serum 25(OH)D levels were measured at the time of enrollment in 1998-1999, and participants were followed up for mortality. Results: During 6.5 years of follow-up, 228 (22.7%) participants died, of whom 107 died due to cardiovascular diseases. Compared with participants in the highest quartile of serum 25(OH)D (426.5 ng/ml) (to convert to nmol/l, multiply by 2.496), those in the lowest quartile (o10.5 ng/ml) had increased risk of all-cause mortality (Hazard Ratio (H.R.) 2.11, 95% Confidence Interval (95% C.I.): 1.22-3.64, P ¼ 0.007) and cardiovascular disease mortality (H.R. 2.64, 95% C.I.: 1.14-4.79, P ¼ 0.02), in multivariate Cox proportional hazards models that adjusted for age, sex, education, season, physical activity and other potential confounders. Conclusions: Older community-dwelling adults with low serum 25(OH)D levels are at higher risk of all-cause and cardiovascular disease mortality.
Introduction
Worldwide, the population of individuals aged X65 years was 420 million in 2000, and it is expected to increase to 973 million by 2030 (Ferrucci et al., 2008) . By 2030, it is estimated that individuals aged X65 years will comprise more than 20% of the North American population (Ferrucci et al., 2008) . Vitamin D deficiency, as assessed by low serum 25-hydroxyvitamin D (25(OH)D) levels, the standard measure of vitamin D status, is highly prevalent among older, community-dwelling adults (Zadshir et al., 2005; Holick, 2006) and has an extremely high prevalence among those who are institutionalized (Gloth et al., 1995; Thomas et al., 1998) . Older adults may be at higher risk of vitamin D deficiency because both the level of outdoor activity (Scragg and Camargo, 2008) and the cutaneous production of vitamin D (MacLaughlin and Holick, 1985) decrease with age. Vitamin D deficiency will be a growing public health problem because of the global shifts toward an aged population in much of the world.
Vitamin D deficiency is associated with an increased risk of osteopenia, osteoporosis, muscle weakness, poor physical performance (Houston et al., 2007) , falls (Bischoff-Ferrari et al., 2004) and fractures (Bischoff-Ferrari et al., 2005) . Low serum 25(OH)D levels are associated with hypertension (Lind et al., 1995; Martins et al., 2007) , coronary heart disease (Kim et al., 2008) , myocardial infarction (Giovannucci et al., 2008) , heart failure (Zittermann et al., 2007; Kim et al., 2008) , stroke (Poole et al., 2006; Pilz et al., 2008) and independently predict cardiovascular disease (Wang et al., 2008) . A recent study showed that patients undergoing coronary angiography at a tertiary care center, who had low serum 25(OH)D levels, were at higher risk of all-cause and cardiovascular disease mortality . Participants, aged X20 years, in the Third National Health and Nutrition Examination Survey (NHANES III), who had lower serum 25(OH)D levels, were at an increased risk of all-cause but not cardiovascular disease mortality (Melamed et al., 2008) .
Although vitamin D deficiency is highly prevalent in the elderly, the relationship between low serum 25(OH)D levels and mortality has not been well characterized. We hypothesized that older, community-dwelling men and women with low serum 25(OH)D levels were at higher risk of all-cause and cardiovascular disease mortality. To address this hypothesis, we examined the relationship between serum 25(OH)D and mortality in a population-based sample of older, community-dwelling men and women in Tuscany, Italy.
Subjects and methods
The study subjects consisted of men and women, aged X65 years, who participated in the Invecchiare in Chianti, 'Aging in the Chianti Area' (InCHIANTI) study, conducted in two small towns in Tuscany, Italy. The rationale, design and data collection have been described elsewhere, and the main outcome of this longitudinal study is mobility disability (Ferrucci et al., 2000) . Briefly, in August 1998, 1270 people aged X65 years were randomly selected from the population registry of Greve in Chianti (population 11 709) and Bagno a Ripoli (population4704), and of 1256 eligible subjects, 1155 (90.1%) agreed to participate. Of the 1155 participants, 1043 (90.3%) participated in blood collection. During 6.5 years of follow-up, 228 participants died, 34 refused to participate in the study and 16 moved away from the area. Those who refused to participate in the follow-up or those who moved away were known to be alive at the time of censoring of this analysis. Participants received an extensive description of the study and participated after written, informed consent. The study protocol complied with the Declaration of Helsinki and was approved by the Italian National Institute of Research and Care on Aging Ethical Committee and by the Institutional Review Board of the Johns Hopkins University School of Medicine.
Demographic information, including total years of formal education, as well as information on smoking and medication use were collected using standardized questionnaires. All participants were examined by a trained geriatrician, and diseases were ascertained according to standard, pre-established criteria and algorithms based on those used in the Women's Health and Aging Study for diabetes mellitus, coronary heart disease, chronic heart failure, stroke and cancer (Guralnik et al., 1995) .
Weight was measured using a high-precision mechanical scale. Standing height was measured to the nearest 0.1 cm. Body mass index (BMI) was calculated as weight/height 2 (kg/m 2 ). Mini-Mental State Examination (MMSE) was administered at enrollment, and an MMSE score of o24 was considered consistent with cognitive impairment (Folstein et al., 1975) . Physical activity in the previous year was based on responses to multiple questions and was rated as sedentary (inactive or light-intensity physical activity, such as walking or light housework o1 h per week), light physical activity (light physical activity 2-4 h per week) and moderate-high physical activity (light physical activity 44 h per week and/or moderate physical activity, such as brisk walking, playing soccer, gardening X1 h per week) (Ruggiero et al., 2007) . Season of the year (winter: December-February; spring: March-May; summer: June-August; autumn: September-November) was included as a categorical variable to account for seasonal effects on vitamin D levels. Renal insufficiency was defined as estimated glomerular filtration rate of o60 ml/min per 1.73 m 2 using the four-variable Modification of Diet in Renal Disease Study equation of Levey et al. (1999) .
Blood samples were collected in the morning after a 12-h fast. Aliquots of serum and plasma were immediately obtained and stored at À80 1C. Serum 25(OH)D levels were measured at enrollment and at the 3-year follow-up visit using a radioimmunoassay (DiaSorin, Stillwater, MN, USA) with intra-assay and inter-assay coefficients of variation of 8.1 and 10.2%, respectively (Maggio et al., 2005) . Serum intact parathyroid hormone (PTH) levels were measured using a two-site immunoradiometric assay kit (N-tact PTHSP, DiaSorin) with intra-assay and inter-assay coefficients of variation of o3.0 and 5.5%, respectively. Serum creatinine was measured by a standard creatinine Jaffe method (Roche Diagnostics, Mannheim, Germany). Commercial enzymatic tests (Roche Diagnostics) were used for measuring serum total cholesterol, triglycerides and high-density lipoprotein (HDL) cholesterol concentrations. Low-density lipoprotein cholesterol was calculated by the Friedewald formula (Friedewald et al., 1972) .
Participants were evaluated again for a 3-year follow-up visit from 2001 to 2003 (n ¼ 926) and for a 6-year follow-up visit from 2004 to 2006 (n ¼ 844). At the end of the field data collection, mortality data of the original InCHIANTI cohort were collected using data from the Mortality General Registry maintained by the Tuscany Region and the death certificates that are deposited immediately after death at the Registry office of the Municipality of residence. Cardiovascular disease mortality was defined by the death codes 390-459 from the ninth version of the ICD (International Classification of Diseases) (United States Department of Health and Human Services, 2006) .
Variables are reported as medians (25th, 75th percentiles) or as percentages. Serum 25(OH)D levels were divided into quartiles: o10.5, 10.5-16.0, 16.1-25.6, 425.6 ng/ml. Characteristics of subjects were compared between groups using Kruskal-Wallis tests. Cox proportional hazards models were used to examine the relationship between serum 25(OH)D and all-cause and cardiovascular disease mortality. We adjusted for possible confounders in multivariate Cox proportional hazards models for mortality using conventional cardiovascular risk factors. The models were tested for possible interactions and collinearity, and no significant interactions or collinearity were found. Pearson's correlation was used to examine the correlation between serum 25(OH)D measurements at enrollment and 3-year followup. Kaplan-Meier curves were used for survival by quartile of serum 25(OH)D, and survival curves were compared using log-rank tests. The statistical program used was SAS (SAS Institute, Cary, NC, USA). The level of significance used in this study was Po0.05.
Results
The characteristics of participants by quartile of serum 25(OH)D at enrollment are shown in Table 1 . Participants in the lower quartiles of serum 25(OH)D were older, more likely to be female, current non-smokers, physically inactive and were more likely to have low education and MMSE scores, heart failure, stroke or renal insufficiency. Participants in the lower quartiles of serum 25(OH)D were more likely to have had their serum vitamin D measured in autumn or winter. Participants did not have any significant differences across quartile of serum 25(OH)D by total cholesterol, HDL cholesterol, low-density lipoprotein cholesterol or triglycerides, or by the prevalence of hypertension, angina, peripheral artery disease, diabetes mellitus or cancer. During 6.5 years of follow-up, 228 (22.7%) of 1,006 participants died. The main causes of death were cardiovascular disease (47.3%), cancer (24.1%), respiratory disease (9.0%) and other (19.2%), and unknown diseases (0.4%). The survival of participants by quartile of serum 25(OH)D for all-cause mortality is shown in Figure 1 . Participants in the lowest quartile of serum 25(OH)D had significantly shorter survival than did those in the highest quartile of serum 25(OH)D for all-cause mortality. In multivariate Cox proportional hazards models adjusting for age, sex, education and season, and additionally for BMI, smoking, aspirin use, physical activity, total cholesterol, HDL cholesterol, MMSE score and chronic diseases, participants in the lowest quartile of serum 25(OH)D had a significantly increased risk of allcause mortality compared with those in the highest quartile of serum 25(OH)D (Table 2) . Participants in the second and third quartiles of serum 25(OH)D also had a higher risk of allcause mortality compared with those in the highest quartile of serum 25(OH)D, but the results did not reach statistical significance for those in the second quartile of serum 25(OH)D.
During follow-up, 107 participants died due to cardiovascular diseases. The survival of participants by quartile of serum 25(OH)D for cardiovascular disease mortality is shown in Figure 2 . Participants in the lowest quartile of serum 25(OH)D had significantly shorter survival than did those in the highest quartile of serum 25(OH)D for cardiovascular disease mortality.
In multivariate Cox proportional hazards models adjusting for age, sex, education and season, and additionally for BMI, smoking, aspirin use, physical activity, total cholesterol, HDL cholesterol, MMSE score and renal insufficiency, participants in the lowest quartile of serum 25(OH)D had a significantly increased risk of cardiovascular disease mortality compared with those in the highest quartile of serum 25(OH)D (Table 3) . Participants in the second and third quartiles of serum 25(OH)D also had a higher risk of cardiovascular mortality than did those in the highest quartile of serum 25(OH)D, but the results did not reach statistical significance for those in the second quartile of serum 25(OH)D. There were 52 deaths from cancer, and quartiles of 25(OH)D were not significantly related to cancer mortality.
Median (25th, 75th percentile) serum PTH concentrations were 27.2 (19.7, 38.3) ng/l among participants who died from all causes compared with 21.6 (15.4, 30.3) ng/l among participants who survived (Po0.0001). Addition of PTH and calcium to the multivariate Cox proportional hazards model that also adjusted for age, sex, season, BMI, smoking, aspirin use, physical activity, total and HDL cholesterol, MMSE score and chronic diseases did not substantially change the relationship between the highest and lowest quartiles of serum 25(OH)D and mortality (hazard ratio (H.R.) 1.97, 95% confidence interval (95% C.I.): 1.11-3.47, P ¼ 0.02), or between the highest and second and highest and third quartiles, respectively (H.R. 1.51, 95% C.I.: 0.89-2.57, P ¼ 0.13; H.R. 1.88, 95% C.I.: 1.15-3.09, P ¼ 0.01).
Median ( In an alternative analysis, we excluded participants who died within 1 year of enrollment in the study to have a time lag. A total of 160 participants died from all causes after the 1-year time lag. In a multivariate Cox proportional hazards model for all-cause mortality that adjusted for age, sex, education, season, BMI, smoking, aspirin use, physical activity, total cholesterol, HDL cholesterol, MMSE score and chronic diseases as in the final model in Table 2 , the H.R. (95% C.I.) for 25(OH)D quartiles of o10.5, 10.5-16.0 and 16.1-25.6 ng/ml were 1.82 (1.03, 3.21), 1.38 (0.80, 2.38) and 1.67 (1.01, 2.79), respectively. A total of 79 participants died due to cardiovascular disease after the 1-year time lag. In a multivariate Cox proportional hazards model for cardiovascular mortality that adjusted for age, sex, education, season, BMI, smoking, aspirin use, physical activity, total cholesterol, HDL cholesterol, MMSE score and renal insufficiency as in the final model in Table 3 , the H.R. (95% C.I.) for 25(OH)D quartiles of o10.5, 10.5-16.0, 16.1-25.6 ng/ml were 2.15 (0.92, 5.04), 1.49 (0.67, 3.34) and 1.78 (0.84, 3.77), respectively.
A total of 729 participants had serum 25(OH)D measurements at both enrollment and 3-year follow-up visit, of whom 92 (12.6%) died from all causes during the follow-up period from 3 to 6.5 years after enrollment. The Pearson correlation between serum 25(OH)D at enrollment and the 3-year follow-up visit was 0.45 (Po0.0001). Participants were divided into four groups on the basis of serum 25(OH)D measurements at enrollment and the 3-year follow-up visit:
(1) above the median at both enrollment and 3-year followup, (2) below the median at enrollment and above the median at the 3-year follow-up, (3) above the median at enrollment and below the median at the 3-year follow-up and (4) below the median at both enrollment and 3-year follow-up. The mortality rates in the four groups were 8.3, 10.8, 14.5 and 17.3% (P ¼ 0.02), respectively.
Discussion
This study shows that older, community-dwelling men and women with low serum 25(OH)D levels (lowest quartile, o10.5 ng/ml; o26.2 nmol/l) had a significantly higher risk of both all-cause and cardiovascular disease mortality compared with those with higher serum 25(OH)D concentrations (highest quartile, 425.6 ng/ml; 463.9 nmol/l), after adjusting for demographic and other risk factors. The study corroborates the findings of the Hoorn study (Pilz et al., 2009) , and extends the association between vitamin D and cardiovascular mortality in a larger study cohort with lower levels of 25(OH)D. Another previous study showed that in a selected group of patients undergoing coronary angiography, low serum 25(OH)D levels were associated with increased all-cause and cardiovascular disease mortality . In the general population of adults, aged X20 years in NHANES III, low serum 25(OH)D level was an independent predictor of all-cause mortality, but the relationship between low serum 25(OH)D level and cardiovascular disease mortality did not reach statistical significance (Melamed et al., 2008) . The results from NHANES III and this study are not Vitamin D and mortality in older adults RD Semba et al directly comparable because of the differences in age ranges between the two studies. In this study, participants who maintained a serum 25(OH)D level above the median at both enrollment and 3 years later, or those who had a serum 25(OH)D level below the median at enrollment but above the median 3 years later were at a lower risk of mortality, compared with those who remained below the median at both enrollment and 3-year follow-up, or those who dropped from above the median at enrollment to below the median at the 3-year follow-up. These findings suggest that those who maintain a high serum 25(OH)D level over time are at a lower risk of all-cause mortality.
Several biological mechanisms that could explain a possible causal relationship between vitamin D deficiency and mortality have been proposed. The active form of vitamin D, 1,25-dihydroxyvitamin D, has pleiotropic effects, and the vitamin D receptor is widely distributed in tissues (Holick, 2007) . Vitamin D has a role in the regulation of the renin-angiotensin axis (Li et al., 2002) , modulation of cellular proliferation and differentiation (Thorne and Campbell, 2008) , cytokine production (Schleithoff et al., 2006) and atherosclerosis (Richart et al., 2007; Cardus et al., 2009) . Low serum 25(OH)D levels have been shown to predict the risk of coronary artery calcification (de Boer et al., 2009) , and vitamin D may also have a role in arterial stiffness (Andrade et al., 2008) . The wide role that vitamin D has in different tissues may account for the associations between vitamin D deficiency and cardiovascular disease (Martins et al., 2007; Wang et al., 2008) , cancer (Davis, 2008) and mortality Melamed et al., 2008) . The effect of vitamin D on mortality may be indirect through hyperparathyroidism secondary to vitamin D insufficiency (Lips, 2001) . PTH levels were significantly higher among those who died; however, the addition of PTH to models of 25(OH)D and all-cause and cardiovascular disease mortality did not substantially change the relationship between serum 25(OH)D and mortality.
Vitamin D deficiency is often defined as a serum 25(OH)D level o20 ng/ml (50 nmol/l) (Holick, 2007) . Using this criterion, the majority of participants in this study were deficient in vitamin D. The median serum 25(OH)D concentration of 16 ng/ml (40 nmol/l) among participants in this study is lower than the mean 25(OH)D concentrations of B28 ng/ml described among participants, aged X60 years, in NHANES III (Zadshir et al., 2005) , but serum 25(OH)D levels were measured in NHANES III from 89 survey locations across the United States and during warmer months in the northern locations, when sunlight is more abundant (Martins et al., 2007) .
Vitamin D is found in a limited number of dietary sources such as oily fish, eggs, and vitamin D-fortified milk, cereals, margarine and yogurts. The current dietary recommendations for adequate daily intake of vitamin D are 400 IU for adults aged 51-70 years and 600 IU for adults aged X71 years (Food and Nutrition Board, 1997), but recent evidence suggests that the recommended adequate daily intake may need to be increased to 800 IU per day (Holick, 2007) . Among the participants aged X60 years in NHANES III, those who participated in daily outdoor activities had mean serum 25(OH)D concentrations that were 30.8 ng/ml (77 nmol/l) (Scragg and Camargo, 2008) , well above the cutoff of 50 nmol/l for vitamin D sufficiency. Older adults may require both greater daily outdoor activities and higher dietary intake of vitamin D to reduce the risk of vitamin D deficiency.
This study is limited in that phosphate levels were not collected and could be a potential confounder in the relationship between vitamin D and mortality. There may be other unmeasured confounding factors in the study, as it is generally not possible to account for all confounders in longitudinal studies. As the study is observational, causality cannot be established. Further studies are also required to examine the relationship between serum 25(OH)D over time and mortality. In an alternative analysis, PTH was added as a covariate to the model, and it may not be completely accurate to adjust for PTH as it might mediate the relationship between 25(OH)D and mortality. This study may possibly underestimate the relationship between low 25(OH)D and mortality as the reference quartile of 25(OH)D comprised many participants who were still in the insufficient range of 25(OH)D.
A recent meta-analysis of randomized controlled trials of vitamin D supplementation suggests that vitamin D supplementation may reduce mortality among older adults (Autier and Gandini, 2007) . Most of the trials in the meta-analysis were conducted among older adults who were at high risk of falls or fractures, and the main outcomes were usually bone density, falls and clinical fractures, rather than mortality (Autier and Gandini, 2007) . The authors recommended that randomized, placebo-controlled clinical trials were required among people aged X50 years for at least 6 years with mortality as the primary outcome to definitively address the issue of vitamin D supplementation and mortality (Autier and Gandini, 2007) .
In conclusion, older community-dwelling men and women with low serum 25(OH)D levels are at an increased risk of all-cause and cardiovascular disease mortality.
